THURSDAY 6 SEPTEMBER    
Room WILLEM BURGER VAN WEELDE  VAN DER VORM  JURRIAANSE EDUARD FLIPSE
Time/Society  ESVC  ESVONC/ESCG 

SCH  ESVIM/ISCAID 

EDUCATION STREAM
09.00-09.40

 

 

Chad Johannes (US)
Evolving the clinical approach to Canine gastrointestinal cancer

09.00-09.15
Lawrence
SCH-O-1
09.15-09.30
Oliveira Leal
SCH-O-2
09.30-09.45 
Sato
SCH-O-3

Chick Weisse (US)
Interventional oncology: new treatments for difficult cancer cases
 Pascaline Pey (I)
RESIDENT MASTERCLASS
Interpretation of thoracic radiographs
09.45-10.25

Jonathan Elliott (UK)
Cardiovascular manifestations of feline chronic kidney disease

Chad Johannes (US)
New science impacting the clinical approach to Feline gastrointestinal cancer

09.45-10.00
Ambrosini
SCH-O-4
10.00-10.15
Ferreira
SCH-O-5

Allyson Berent (US)
Interventional radiology and endocscopy of the (upper) urinary tract

10.30-11.15

COFFEE BREAK – EXHIBITION
11.20-12.00

Luca Ferasin (GB)
Cardiac effects of hypo and hyperthyroidism in dogs and cats 

 Charlotte Reinhard Bjornvad (DK)
Nutrition in GI cancer
Cynthia Webster (US)
Evidence to support the role of autoimmunity in canine chronic hepatitis
Chick Weisse (US)
Hepatic vascular anomalies: recent lessons learned using interventional radiology

 

12.05-12.45

Luca Ferasin (GB)
Effects of respiratory diseases on the heart

  Charlotte Reinhard Bjornvad (DK)
Nutraceuticals in GI cancer
Cynthia Webster (US)
Evidence based recommendations on the treatment of canine chronic hepatitis
 Allyson Berent (US)
Novel interventional therapies of urinary incontinence

12.50-14.20

LUNCH BREAK – EXHIBITION

13.20-14.15

Cardiology Diplomate Meeting 

Oncology Diplomates meeting  SCH AGM  ESVIM Board Meeting   
      
Time/Society  ESVC abstracts ESVONC abstracts SCH  ESVIM 

 
14.25-15.05

14.25-14.40
Rishniw
ESVC-O-1
14.40-14.55
Bouvard
ESVC-O-2
14.55-15.10
Bouvard
ESVC-O-3

14.25-14.40
Weber
ESVONC-O-1
14.40-14.55
Treggiari
ESVONC-O-2
14.55-15.10
Del Busto Castro
ESVONC-O-3

John Cullen (US)
Grading and staging of chronic hepatitis: advances since the 2008 WSAVA guidelines

 Federica Rossi (I)
How can contrast enhanced ultrasonography (CEUS) help the internist?

 

15.10-15.50

15.10-15.25
Novo Matos
ESVC-O-4
15.25-15.40
Beijerink
ESVC-O-5
15.40-15.55 
Mateos Panero
ESVC-O-6

15.10-15.25
Holdsworth
ESVONC-O-4
15.25-14.40
McNaught
ESVONC-O-5
15.40-15.55
Stiborova
ESVONC-O-6

JAN ROTHUIZEN AWARD for best abstract  

John Cullen (US)
Hepatic fibrosis: new insights into pathogenesis and diagnosis

Kathelijne Peremans (B)
Scintigraphy and PET scan in small animals, what are the indications?

15.55-16.35

15.55-16.10
Rishniw 
ESVC-O-7
16.10-16.25
Takano
ESVC-O-8
16.25-16.40
Betschart
ESVC-O-9

15.55-16.10
Queiroga
ESVONC-O-7
16.10-16.25
Thumser-Henner
ESVONC-O-8
16.25-16.40
Milevoj
ESVONC-O-9
16.40-16.55
Kimura
ESVONC-O-10

Abdullah Pan (NL)
Prevention and treatment for hepatitis E virus infection: an emerging zoonotic pathogen 

 

16.40-17.40

POSTER RECEPTION   

17.45        ECVIM-CA AGM